GPC2 as an immunotherapeutic target in medulloblastoma and other pediatric brain tumors

CBTTC cell lines are important to this project to provide newly developed cellular brain tumor models to characterize for GPC2 expression and to test the efficacy of this GPC2 directed ADC. Commercially available cell lines will also be used as additional pediatric brain tumor preclinical cellular models.